Error: Could not add to watchlist. X

Hyperion Therapeutics Inc

+ Watchlist
HPTX:US
Acquired
HPTX:US was acquired by HZNP:US
USD
Volume
0
52Wk Range
20.23 - 46.96
Volume
0
52Wk Range
20.23 - 46.96
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.85
Market Cap (USD)
-
Shares Outstanding (m)
20.977
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Hyperion Therapeutics Inc. operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.
ADDRESS
2000 Sierra Point Parkway
Suite 400
Brisbane, CA 94005
United States
PHONE
1-650-745-7802
  • Timothy P Walbert
    President/CEO
  • Paul W Hoelscher
    CFO/Secretary
  • Jeffrey W Sherman
    Exec VP/Chief Medical Officer
  • Robert F Carey "Bob"
    Exec VP/Chief Business Officer
  • Christine A Nash
    Senior VP/Chief Commercial Ofcr
Show More